{"ModuleTitle": "Company Description", "CompanyName": "ImmuCell Corporation", "Symbol": "ICCC", "Address": "56 EVERGREEN DR, PORTLAND, Maine, 04103, United States of America", "Phone": "2078782770", "Industry": "Biotechnology: In Vitro & In Vivo Diagnostic Substances", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "This Annual Report on Form 10-K contains \"forward-looking statements\" within the\r\nmeaning of Section 27A of the Securities Act of 1933 and Section 21E of the\r\nSecurities Exchange Act of 1934.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f27%2f0001213900-20-007650.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Joseph H. Crabb", "title": "Chief Scientific Officer & Vice President"}, {"name": "Michael F. Brigham", "title": "President, CEO, Secretary, Treasurer & Director"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}